Mitigating cutaneous side effects of lamotrigine.
Antai-Otong
Deborah
D
deborah.antai-otong@med.va.gov
D018692:Antimanic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001714:Bipolar Disorder / Q000188:drug therapy*; D011307:Drug Prescriptions; D005076:Exanthema / Q000139:chemically induced*; D006801:Humans; D000077213:Lamotrigine; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D014227:Triazines / Q000009:adverse effects* / Q000627:therapeutic use
D018692:Antimanic Agents; D014227:Triazines; D000077213:Lamotrigine